These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4476752)

  • 1. [Comparison between interactions of alpha- and beta-cyclodextrin with barbituric acid derivatives].
    Koizumi K; Mitsui K; Higuchi K
    Yakugaku Zasshi; 1974 Dec; 94(12):1515-9. PubMed ID: 4476752
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of beta-cyclodextrin on sleeping time induced by barbituric acid derivatives in mice.
    Shirakura O; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1985 Aug; 33(8):3517-21. PubMed ID: 4085080
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative structure-stability relationships among inclusion complexes of cyclodextrins. I: Barbituric acid derivatives.
    Lopata A; Darvas F; Stadler-Szóke A; Szejtli J
    J Pharm Sci; 1985 Feb; 74(2):211-3. PubMed ID: 3989695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion complexation of barbiturates with beta-cyclodextrin in aqueous solution. I. Spectroscopic study on the mode of interaction.
    Otagiri M; Miyaji T; Uekama K; Ikeda K
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1146-54. PubMed ID: 1021280
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions of alpha- and beta-cyclodextrin with several non-steroidal antiinflammatory drugs in aqueous solution.
    Hamada Y; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1975 Jun; 23(6):1205-11. PubMed ID: 241500
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous determination of complexation equilibrium constants for conjugated guest species by extended potentiometric titration method: on barbiturate-beta-cyclodextrin system.
    Miyaji T; Kurono Y; Uekama K; Ikeda K
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1155-9. PubMed ID: 1021281
    [No Abstract]   [Full Text] [Related]  

  • 7. Utilization of cyclodextrin complexation for separation of E, A, and B prostaglandins by ion-exchange liquid chromatography.
    Uekama K; Hirayama F; Ikeda K; Inaba K
    J Pharm Sci; 1977 May; 66(5):706-10. PubMed ID: 874756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on inclusion compounds. 3. Interaction of -Schardinger dextrin with pharmaceuticals. 2. Investigation of solubilizing and stabilizing effects of barbituric acid derivatives].
    Koizumi K; Fujimura K
    Yakugaku Zasshi; 1972 Jan; 92(1):32-6. PubMed ID: 5063320
    [No Abstract]   [Full Text] [Related]  

  • 9. Multimodal inclusion complexes between barbiturates and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution: isothermal titration microcalorimetry, (13)C NMR spectrometry, and molecular dynamics simulation.
    Aki H; Niiya T; Iwase Y; Yamamoto M
    J Pharm Sci; 2001 Aug; 90(8):1186-97. PubMed ID: 11536223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of pharmaceuticals with Schardinger dextrins. VI. Interactions of beta-cyclodextrin, sodium deoxycholate, and deoxycholic acid with amines and pharmaceutical agents.
    Lach JL; Pauli WA
    J Pharm Sci; 1966 Jan; 55(1):32-8. PubMed ID: 5918647
    [No Abstract]   [Full Text] [Related]  

  • 11. Microcalorimetric investigations of pharmaceutical complexes. I. Drugs and beta-cyclodextrin.
    Hardee GE; Otagiri M; Perrin JH
    Acta Pharm Suec; 1978; 15(3):188-99. PubMed ID: 716952
    [No Abstract]   [Full Text] [Related]  

  • 12. Stoichiometric model of alpha-cyclodextrin complex formation.
    Rosanske TW; Connors KA
    J Pharm Sci; 1980 May; 69(5):564-7. PubMed ID: 7381745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improvements of some pharmaceutical properties of aralkylalcohols by cyclodextrin complexation].
    Uekama K; Oh K; Hirayama F; Otagiri M; Shibata M; Ohtani Y; Yamada Y; Sugiyama Y
    Yakugaku Zasshi; 1982 Dec; 102(12):1141-9. PubMed ID: 7182449
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of the hypnotic potency of barbiturates by inclusion complexation with beta-cyclodextrin.
    Koizumi K; Miki H; Kubota Y
    Chem Pharm Bull (Tokyo); 1980 Jan; 28(1):319-22. PubMed ID: 7363375
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of some benzothiadiazine diuretics with beta-cyclodextrin.
    Abdel-Rahman SI; el-Sayed AM
    Acta Pharm Hung; 1990 May; 60(2-3):69-75. PubMed ID: 2386074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrin complexation of barbiturates in aqueous solution.
    Han SM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2825-7. PubMed ID: 6524658
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.
    Loftsson T; Bodor N
    Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benzylisoquinoline alkaloid reactions with barbiturates. Reaction of papaverine with sodium phenobarbital. III. Avoidance of incompatibility by using the beta-cyclodextrin inclusion complex].
    Rácz I; Plachy J; Szabóné Tábori M; Stadlerné Szöke A; Vikmon M; Szejtli J
    Acta Pharm Hung; 1984 Jul; 54(4):154-9. PubMed ID: 6485810
    [No Abstract]   [Full Text] [Related]  

  • 19. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
    Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the Schardinger dextrins; the preparation and solubility characteristics of alpha, beta and gamma dextrins.
    FRENCH D; LEVINE ML
    J Am Chem Soc; 1949 Jan; 71(1):353-6. PubMed ID: 18108971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.